Blumberg, Bruce

The nuclear receptor superfamily: the second decade

Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell

Estrogen and related hormone effectsNuclear Receptors and Signaling

Cited by 6,964

Metabolism disrupting chemicals and metabolic disorders

Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., Nadal, A., Palanza, P., Panzica, G., Sargis, R., et al. (2017) · Reproductive Toxicology

Effects and risks of endocrine disrupting chemicalsBirth, Development, and Health

Cited by 1,101

The dynamic genome of Hydra

Chapman, J. A., Kirkness, E. F., Simakov, O., Hampson, S. E., Mitros, T., Weinmaier, T., Rattei, T., Balasubramanian, P. G., Borman, J., Busam, D., et al. (2010) · Nature

Marine Invertebrate Physiology and EcologyDevelopmental Biology and Gene Regulation

Cited by 810

Retinoic acid signaling and neuronal differentiation

Janesick, A., Wu, S. C., & Blumberg, B. (2015) · Cellular and Molecular Life Sciences

Neurogenesis and neuroplasticity mechanismsRetinoids in leukemia and cellular processes

Cited by 295

Minireview: The Case for Obesogens

Grün, F., & Blumberg, B. (2009) · Molecular Endocrinology

Effects and risks of endocrine disrupting chemicalsRegulation of Appetite and Obesity

Cited by 188

PFAS and Potential Adverse Effects on Bone and Adipose Tissue through Interactions with PPARγ

Kirk, A. B., Michelsen-Correa, S., Rosen, C., Martin, C. F., & Blumberg, B. (2021) · Endocrinology

Per- and polyfluoroalkyl substances researchPeroxisome Proliferator-Activated Receptors

Cited by 90

Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action

Mohajer, N., Du, C. Y., Checkcinco, C., & Blumberg, B. (2021) · Frontiers in Endocrinology

Effects and risks of endocrine disrupting chemicalsAdipokines, Inflammation, and Metabolic Diseases

Cited by 72